Category Business

Diagnostic Collaboration and Licensing Deals Analysis Report and Directory 2023: Comprehensive Insights on Agreements Made by Major Biopharmaceutical Companies Globally – ResearchAndMarkets.com

The “Diagnostic Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. This report contains a comprehensive listing of 2087 diagnostic deals announced since 2016 including financial terms where available including links to online deal records of actual diagnostic partnering deals as…

Read MoreDiagnostic Collaboration and Licensing Deals Analysis Report and Directory 2023: Comprehensive Insights on Agreements Made by Major Biopharmaceutical Companies Globally – ResearchAndMarkets.com

REGENERON COMMITS $34 MILLION OVER FIVE YEARS TO CONTINUE TO SPONSOR THE REGENERON INTERNATIONAL SCIENCE AND ENGINEERING FAIR (ISEF)

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (Society) today announced that Regeneron is increasing and extending its commitment as the title sponsor of the Regeneron International Science and Engineering Fair (ISEF), the world’s largest high school science and engineering competition, with a total…

Read MoreREGENERON COMMITS $34 MILLION OVER FIVE YEARS TO CONTINUE TO SPONSOR THE REGENERON INTERNATIONAL SCIENCE AND ENGINEERING FAIR (ISEF)

Bayer collaboration with Microsoft connects farm data to address lack of data interoperability in agriculture

Bayer today announced at Agritechnica, the world’s leading trade fair for agricultural machinery, an update on the strategic collaboration with Microsoft: New data connectors allow secure, compliant exchange of farm data between Bayer’s flagship digital farming product Climate FieldView™ and…

Read MoreBayer collaboration with Microsoft connects farm data to address lack of data interoperability in agriculture

Novo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark

Novo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark Novo Nordisk today announced plans to invest more than 42 billion Danish kroner starting in 20231 to expand existing manufacturing facilities in Kalundborg, Denmark,…

Read MoreNovo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark

BioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market

BioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market BioPhy today launched its AI operating system that radically accelerates the identification and development of the most promising drug candidates. By combining scientific, clinical and regulatory insights…

Read MoreBioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market

Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate

Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate Merck, a leading science and technology company, today announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui). The partnership includes an…

Read MoreMerck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate

Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases

Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that the…

Read MoreGilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases

TOGETHER FOR CHANGE GENOMICS AND EQUITY INITIATIVE LAUNCHED BY A COALITION OF MEHARRY MEDICAL COLLEGE, REGENERON GENETICS CENTER, ASTRAZENECA, NOVO NORDISK, AND ROCHE TO IMPROVE HEALTH OUTCOMES FOR PEOPLE OF AFRICAN ANCESTRY

TOGETHER FOR CHANGE GENOMICS AND EQUITY INITIATIVE LAUNCHED BY A COALITION OF MEHARRY MEDICAL COLLEGE, REGENERON GENETICS CENTER, ASTRAZENECA, NOVO NORDISK, AND ROCHE TO IMPROVE HEALTH OUTCOMES FOR PEOPLE OF AFRICAN ANCESTRY NASHVILLE, Tenn. and TARRYTOWN, N.Y. and WILMINGTON, Del. and BAGSVAERD, Denmark and BASEL, Switzerland, Oct. 18, 2023 (GLOBE…

Read MoreTOGETHER FOR CHANGE GENOMICS AND EQUITY INITIATIVE LAUNCHED BY A COALITION OF MEHARRY MEDICAL COLLEGE, REGENERON GENETICS CENTER, ASTRAZENECA, NOVO NORDISK, AND ROCHE TO IMPROVE HEALTH OUTCOMES FOR PEOPLE OF AFRICAN ANCESTRY

Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK

Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK –Promega Corporation today announced it plans to develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit with GSK to identify adult cancer patients with…

Read MorePromega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK

Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care

Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that…

Read MoreRockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care

Automata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering

Automata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering –Automata Technologies, a leading automation company powering life sciences labs, has raised $40m to accelerate its rapid growth and industry presence across…

Read MoreAutomata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering